Author Rudolph, C.

• 2000 | Journal Article
  ​ ​MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage​
  Scheller, J.; Schurer, A.; Rudolph, C.; Hettwer, S. & Kramer, W.​ (2000) 
  Genetics, 155(3) pp. 1069​-1081​.​
  ​Details  PMID  PMC  WoS 

• 2003 | Conference Abstract
  ​ ​Genetic interactions of mph1 mutants from Saccharomyces cerevisiae imploy an involvement in error free bypass of DNA lesions.​
  Schurer, K. A.; Rudolph, C. & Kramer, W.​ (2003)
  Yeast, 20 ​21st International Conference on Yeast Genetics and Molecular Biology​, GOTHENBURG, SWEDEN.
  Chichester​: John Wiley & Sons Ltd.
  ​Details  WoS 

• 2003 | Journal Article
  ​ ​Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)​
  Wunderlich, A.; Kloess, M.; Reiser, M.; Rudolph, C.; Truemper, L. H.; Bittner, S. & Schmalenberg, H. et al.​ (2003) 
  Annals of Oncology, 14(6) pp. 881​-893​.​ DOI: https://doi.org/10.1093/annonc/mdg249 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from homologous recombination, but not from postreplicative repair​
  Schurer, K. A.; Rudolph, C.; Ulrich, H. D. & Kramer, W.​ (2004) 
  Genetics, 166(4) pp. 1673​-1686​.​ DOI: https://doi.org/10.1534/genetics.166.4.1673 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL​
  Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rudolph, C. & Reiser, M. et al.​ (2004) 
  Blood, 104(3) pp. 626​-633​.​ DOI: https://doi.org/10.1182/blood-2003-06-2094 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL​
  Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rube, C. & Rudolph, C. et al.​ (2004) 
  Blood, 104(3) pp. 634​-641​.​ DOI: https://doi.org/10.1182/blood-2003-06-2095 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article
  ​ ​Sonographische Humerustorsionsmessungen bei Kindern und Jugendlichen mit spastischer Hemiparese​
  Katthagen, J. C.; Rudolph, C. & Hell, A. K. ​ (2009) 
  Der Orthopäde, 38(10) pp. 956​-961​.​ DOI: https://doi.org/10.1007/s00132-009-1438-2 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Conference Abstract
  ​ ​CLINICAL OUTCOME IN OLDER AML PATIENTS NOT FIT FOR INTENSIVE CHEMOTHERAPY: RESULTS OF THE POPULATION-BASED AMLSG-BIO (NCT01252485) REGISTRY STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP​
  Schlenk, R. F.; Paschka, P.; Krauter, J.; Luebbert, M.; Brossart, P.; Salih, H. R. & Theobald, M. et al.​ (2015)
  Haematologica, 100 pp. 193​-194. ​20th Congress of European-Hematology-Association​, Vienna, AUSTRIA.
  Pavia​: Ferrata Storti Foundation.
  ​Details  WoS 

• 2017 | Journal Article
  ​ ​Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)​
  Nagel, G.; Weber, D.; Fromm, E.; Erhardt, S.; Lübbert, M.; Fiedler, W. & Kindler, T. et al.​ (2017) 
  Annals of Hematology, 96(12) pp. 1993​-2003​.​ DOI: https://doi.org/10.1007/s00277-017-3150-3 
  ​Details  DOI 

Researcher

Sort

Items per Page